Cyma Life Sciences Private Limited, a active private limited company, was established on 27 July 2007 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2007PTC054924. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
It upholds a compliant status. Employing 8 professional, Its leadership includes Lakshmana Swamy Balusu (Director), Narendra Balusu (Director), Sai Phani Teja Balusu (Director). Past directors included Sanjay Chillakuru Reddy, Sudha Rani Balusu, Amarendra Reddy Kamireddy. It holds ₹9.48 Cr open charges and ₹7.72 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 8-4-376/14 New Sastry Nagar, Sanath Nagar, Hyderabad, Telangana, 500018.
U24232TG2007PTC054924
054924
27 July 2007
₹1.50 Cr
₹1.50 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Cyma Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Lakshmana Swamy Balusu | Director | 27 May 2008 | Current |
| Narendra Balusu | Director | 11 Jun 2008 | Current |
| Sai Phani Teja Balusu | Director | 13 Oct 2021 | Current |
| Sudha Rani Balusu | Director | 01 Apr 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Nov 2008 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Director | 11 Jun 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cyma Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.29% decrease. The company also saw a substantial fall in profitability, with a 35% decrease in profit. The company's net worth moved up by a moderate rise of 8.32%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cyma Life Sciences had a promoter holding of 64.00% and a public holding of 36.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹94,800,000.00
₹77,163,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jul 2024 | Others | ₹4.50 Cr | Open |
| 29 Oct 2018 | Others | ₹4.98 Cr | Open |
| 20 Oct 2010 | State Bank Of India | ₹2.74 Cr | Satisfied |
| 18 Aug 2009 | State Bank Of India | ₹4.98 Cr | Satisfied |
Explore comprehensive loan charge details -
Cyma Life Sciences has a workforce of 8 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cyma Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyma Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Cyma Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Cyma Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 100997855 was registered on 30 Jul 2024. was recorded as a recent event.
A charge with Others of Rs. 4.98 Cr registered on 29 Oct 2018 with Charge ID 100213914 was modified on 29 Dec 2023. was recorded as a recent event.
Sai Phani Teja Balusu was appointed as a Director was appointed as a Director on 13 Oct 2021 & has been associated with this company since 4 years 3 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 4.98 Cr with Charge ID 100213914 was registered on 29 Oct 2018. was documented.
The CIN of Cyma Life Sciences Private Limited is U24232TG2007PTC054924.
Cyma Life Sciences Private Limited is headquartered at 8-4-376/14 New Sastry Nagar, Sanath Nagar, Hyderabad, Telangana, 500018.
Cyma Life Sciences Private Limited was incorporated on 27 July 2007.
The current directors of Cyma Life Sciences Private Limited are
The primary industry of Cyma Life Sciences Private Limited is Manufacturing.
Cyma Life Sciences Private Limited is unlisted.
The authorized capital of Cyma Life Sciences Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
The compliance status of Cyma Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX